Webinar
A Lipid Nanoparticle Quantitative Systems Pharmacology Case Study
Recorded on September 12, 2018 | Applied Biomath

This webinar will present a quantitative systems pharmacology case study which assesses a Lipid Nanoparticle to treat Crigler-Najjar Syndrome Type 1. Learn how the model was used to support translation from preclinical to clinical trials as well as first-in-human dosing.

eBook
2018 Weekly Compendium
Biotech Primer

The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry.

This eBook is a collection of Biotech Primer WEEKLYs from the past 12 months. The Biotech Primer WEEKLY is a one-page, easy-to-ready newsletter delivered each Thursday right to your inbox. If you are not already registered to receive the Biotech Primer WEEKLY register today here.

Download here: 2018 Biotech Primer WEEKLY Compendium

Whitepaper
Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma
Amazon Web Services

Life science companies are responding with Real World Evidence (RWE) programs to capture data from clinical through post-market activities from a variety of sources. Learn how the centralization of data assets enables organizational intelligence by equipping companies to understand the needs of patients and other stakeholders, and how their products can meet them.  Download this Whitepaper!

Webinar
Understanding New Drug Applications (NDAs)
Recorded on August 14, 2018 | Rho

This webinar will help you understand what is involved in an NDA including regulatory strategy, data integration and readiness, and electronic publishing, and provide tips that can help you avoid common pitfalls in the submissions process.

Executive Summary
Executive Summary: Investigator Site Payments Strategy Survey
Bioclinica

As the number of clinical trials increases so does the complexity and number of US and global sites needed to foster trial success. Read what was discovered after a survey on current site payment practices, how these practices are measured, what process improvement initiatives are currently being explored, what are some of the barriers to change, and what site payment trends will occur over the next five years. Download it now!

Survey
The State of Sales Enablement in the Healthcare Industry
FierceMarkets

Take this quick 10 minute survey on on the state of sales enablement in the healthcare industry. A $5 Amazon Gift Card will be sent to the first 50 qualified respondents. Complete the survey now!

Webinar
New Findings from the Veeva 2018 Unified Clinical Operations Survey
July 25, 2018 | 12pm ET / 9am PT | Veeva

Hear new results from one of the industry's largest, global clinical operations surveys, the Veeva 2018 Unified Clinical Operations Survey. The Veeva 2018 Unified Clinical Operations Survey examines the industry’s progress toward a unified clinical operating environment.

Survey
Industry Report: Findings from the 2018 Unified Clinical Operations Survey
Veeva

Learn why unifying clinical applications is an industrywide priority for clinical operations leaders. Read the report.

Webinar
The Changing Landscape of Real-World Evidence and its Impact on Clinical Research
Thursday, June 21, 2018 | 11am ET / 8am PT | TriNetX

Researchers are encumbered with a plethora of disparate data and analytic tools. These assets pose several challenges which need to be overcome to ensure they satisfy their intended purpose. 

Join this webinar to learn how real-time, self-service access to longitudinal patient data is changing the way researchers evaluate treatment effectiveness, safety, protocol design, and more. Register now.

Webinar
Handling Suspected Fraud and Data Fabrication in Clinical Studies
June 13, 2018 | 1pm ET / 10am PT | Rho

Fraud and fabrication is no laughing matter in the realm of clinical trials.

This webinar will outline the ways in which sponsors and CROs can remain diligent by being aware of signs of possible fraud and fabricated data throughout the course of the study.

Show Preview
Your oncology trial is complex. Get specialized expertise, end to end.
Precision for Medicine, Oncology and Rare Disease

The first precision medicine CRO designed specifically for oncology and rare disease, Precision unifies translational science expertise and unparalleled clinical operations to create a more efficient process, deeper data, and an accelerated development pathway for novel treatments.

 

With 1200+ experts worldwide, one core team delivers

 

  • Clinical development planning
  • Expedited study start up enabled by Precision’s Oncology Site Network
  • Personalized clinical trial execution services
  • Specialty labs services and coordination
  • Robust biometrics teams and services

 

Schedule a meeting with our experts at ASCO, Booth 24146, and visit our website

Webinar
505(b)(2) Strategy for Biotech Execs: Positioning Your Products for Success
May 9, 2018 | 11am ET / 8am PT | Camargo

This webinar will benefit Biotech executives interested in aligning their products for success via early strategy for 505(b)(2) drug development. Register Now

Paid Marketplace
AACR Annual Meeting 2018
Charles River

When it comes to choosing a partner, who do you want on your team? How about a provider with 52 patents, 17 candidates and work on 80% of the oncology therapies approved in 2017? Our next success can be yours. Choose Charles River to guide your therapy through the complex path to clinic with proven expertise and the industry’s most comprehensive portfolio. Learn More.

Multimedia
Back from the dead: FierceBiotech Radio at the Battle of the Biotech Bands
FierceBiotech Radio

Here’s a special “risen-from-the-grave” episode covering this year’s Battle of the Biotech Bands, an (almost) annual Boston tradition which sees bands from the biotech industry compete to win prize money for charity.  Download the episode on iTunes or Stitcher, or listen here

Whitepaper
Considering an eTMF Solution? Industry Research Reveals the Top Benefits
Veeva

The largest survey of TMF owners reveals drivers and trends in improving inspection readiness and shortening trial time. Read more.

Webinar
Continuous Flow Chemistry for APIs and Intermediates
Recorded on December 5, 2018 | Cambex

In response to an increasing market demand, Cambrex has invested in a Continuous Flow Center enabling development of previously unfeasible process steps. Register for the Cambrex webinar on Continuous Flow Chemistry for APIs and Intermediates today.

Multimedia
FierceBiotech Radio on GSK's CEO shakeup, Lilly's Alzheimer's uncertainty, and Valeant's latest disaster
FierceBiotech Radio

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the pending retirement of GlaxoSmithKline CEO Andrew Witty, Eli Lilly's bold decision with a big Alzheimer's trial and Valeant Pharmaceuticals' rough week.

Download the episode on iTunes or Stitcher, or listen here.

Multimedia
FierceBiotech Radio on the FDA's new boss, Sanofi's latest shortcut, and a little 'financial innovation'
FierceBiotech Radio

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the confirmation of Robert Califf as the next FDA commissioner, Sanofi's efforts to undercut Novo Nordisk in diabetes, and a novel approach to regulating drug costs. Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe

Multimedia
Pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals
Catalent

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the rise of TV ads for specialty drugs, signs of life in the biotech IPO scene, and the case for Intercept Pharmaceuticals as a buyout target.  Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe.

Multimedia
Pharma's day on the Hill, biotech's paucity of M&A, and the gathering storm of biosimilars
FierceBiotech Radio

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss a bizarre congressional hearing, how biotech's slump affects the buyout climate, and a major development in the world of biosimilars.

Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe. Let us know what you think by dropping a line to [email protected]

Multimedia
Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover
FierceBiotech Radio

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the future of Gilead Sciences, biotech's continued slump on Wall Street, and the latest move in Sanofi's efforts to right the ship.

Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe. Let us know what you think by dropping a line to [email protected]

Multimedia
Shire's byzantine Baxalta pursuit, biotech's pragmatic winter and Valeant's CEO shakeup
FierceBiotech Radio

Fierce editors discuss Shire's increasingly complicated ambition to acquire Baxalta, the changing climate of biotech venture capital and the future of Valeant Pharmaceuticals.  Click here to listen now.